|
Originally published In Press as doi:10.1074/jbc.M111308200 on February 6, 2002
J. Biol. Chem., Vol. 277, Issue 17, 14547-14556, April 26, 2002
Kaposi's Sarcoma-associated Herpesvirus K8 Exon 3 Contains Three
5'-Splice Sites and Harbors a K8.1 Transcription Start Site*
Shuang
Tang and
Zhi-Ming
Zheng
From the HIV and AIDS Malignancy Branch, Center for Cancer
Research, NCI, National Institutes of Health,
Bethesda, Maryland 20892
Kaposi's sarcoma-associated herpesvirus (KSHV)
K8 and K8.1 open reading frames are juxtaposed and span from nucleotide
(nt) 74850 to 76695 of the virus genome. A K8 pre-mRNA overlaps the entire K8.1 coding region, and alternative splicing of KSHV K8 and K8.1
pre-mRNAs each produces three isoforms ( , , and ) of the
mRNAs. We have mapped the 5' end of the K8.1 RNA in
butyrate-induced KSHV-positive JSC-1 cells to nt 75901 in the KSHV
genome and have shown that exon 3 of the K8 pre-mRNA in JSC-1 cells
covers most part of the intron 3 defined previously and has three
5'-splice sites (ss), respectively, at nt 75838, 76155, and 76338. Selection of the nt 75838 5'-ss dictates the K8 mRNA production and
overwhelms the RNA processing. Alternative selection of other two 5'-ss
is feasible and leads to production of two additional bicistronic mRNAs, K8/K8.1 and - . However, the novel bicistronic K8/K8.1 mRNAs translated a little K8 and no detectable K8.1 proteins in 293 cells. Data suggest that production of the K8/K8.1 mRNAs may be an
essential way to control K8 mRNAs, especially K8 , to a threshold
at RNA processing level.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: HIV and AIDS
Malignancy Branch, Center for Cancer Research, NCI, National Institutes of Health, Bldg. 10, Rm. 10S255, MSC 1868, 10 Center Dr., Bethesda, MD
20892-1868. Tel.: 301-594-1382; Fax: 301-480-8250; E-mail: zhengt@exchange.nih.gov.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
V. Majerciak, K. Yamanegi, E. Allemand, M. Kruhlak, A. R. Krainer, and Z.-M. Zheng
Kaposi's Sarcoma-Associated Herpesvirus ORF57 Functions as a Viral Splicing Factor and Promotes Expression of Intron-Containing Viral Lytic Genes in Spliceosome-Mediated RNA Splicing
J. Virol.,
March 15, 2008;
82(6):
2792 - 2801.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kato-Noah, Y. Xu, C. C. Rossetto, K. Colletti, I. Papouskova, and G. S. Pari
Overexpression of the Kaposi's Sarcoma-Associated Herpesvirus Transactivator K-Rta Can Complement a K-bZIP Deletion BACmid and Yields an Enhanced Growth Phenotype
J. Virol.,
December 15, 2007;
81(24):
13519 - 13532.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. S. Markovitz
The Herpes Simplex Virus Type 1 UL3 Transcript Starts within the UL3 Open Reading Frame and Encodes a 224-Amino-Acid Protein
J. Virol.,
October 1, 2007;
81(19):
10524 - 10531.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Majerciak, N. Pripuzova, J. P. McCoy, S.-J. Gao, and Z.-M. Zheng
Targeted Disruption of Kaposi's Sarcoma-Associated Herpesvirus ORF57 in the Viral Genome Is Detrimental for the Expression of ORF59, K8{alpha}, and K8.1 and the Production of Infectious Virus
J. Virol.,
February 1, 2007;
81(3):
1062 - 1071.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Majerciak, K. Yamanegi, and Z.-M. Zheng
Gene Structure and Expression of Kaposi's Sarcoma-Associated Herpesvirus ORF56, ORF57, ORF58, and ORF59
J. Virol.,
December 15, 2006;
80(24):
11968 - 11981.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Haque, V. Wang, D. A. Davis, Z.-M. Zheng, and R. Yarchoan
Genetic Organization and Hypoxic Activation of the Kaposi's Sarcoma-Associated Herpesvirus ORF34-37 Gene Cluster
J. Virol.,
July 15, 2006;
80(14):
7037 - 7051.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Yamanegi, S. Tang, and Z.-M. Zheng
Kaposi's Sarcoma-Associated Herpesvirus K8{beta} Is Derived from a Spliced Intermediate of K8 Pre-mRNA and Antagonizes K8{alpha} (K-bZIP) To Induce p21 and p53 and Blocks K8{alpha}-CDK2 Interaction
J. Virol.,
November 15, 2005;
79(22):
14207 - 14221.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Xu, D. P. AuCoin, A. R. Huete, S. A. Cei, L. J. Hanson, and G. S. Pari
A Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 ORF50 Deletion Mutant Is Defective for Reactivation of Latent Virus and DNA Replication
J. Virol.,
March 15, 2005;
79(6):
3479 - 3487.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Tang, K. Yamanegi, and Z.-M. Zheng
Requirement of a 12-Base-Pair TATT-Containing Sequence and Viral Lytic DNA Replication in Activation of the Kaposi's Sarcoma-Associated Herpesvirus K8.1 Late Promoter
J. Virol.,
March 1, 2004;
78(5):
2609 - 2614.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Liao, Y. Tang, S.-F. Lin, H.-J. Kung, and C.-Z. Giam
K-bZIP of Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 (KSHV/HHV-8) Binds KSHV/HHV-8 Rta and Represses Rta-Mediated Transactivation
J. Virol.,
March 15, 2003;
77(6):
3809 - 3815.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|